Edition:
United Kingdom

Rohto Pharmaceutical Co Ltd (4527.T)

4527.T on Tokyo Stock Exchange

3,900JPY
21 Sep 2018
Change (% chg)

¥75 (+1.96%)
Prev Close
¥3,825
Open
¥3,855
Day's High
¥3,905
Day's Low
¥3,815
Volume
580,000
Avg. Vol
303,819
52-wk High
¥3,905
52-wk Low
¥2,496

Summary

Name Age Since Current Position

Kunio Yamada

62 2018 Chairman of the Board, President, Representative Director

Shinichi Kunisaki

62 2018 Director of Business Strategy Promotion Unit, President of Subsidiary, Director

Lekh Raj Juneja

66 2014 Vice President, Chief Health Officer, Director

Masaya Saito

54 2018 Vice President, President of Subsidiary, Director

Yoichi Kambara

70 2015 Managing Director

Masako Rikiishi

59 2018 Director of Product Marketing, Director

Hidetoshi Segi

56 2018 Director of Business Planning, Director

Hideto Uemura

60 2018 Director of Business Strategy Promotion Unit, Manager of Ueno Technology Center, Director

Tetsumasa Yamada

69 2018 Director of Regenerative Medicine Research Planning, Director

Yasuhiro Yamada

80 1973 Director

Mari Matsunaga

63 2014 Independent Director

Shingo Torii

65 2015 Independent Director

Motohide Arai

2016 Director of Accounting and Finance

Biographies

Name Description

Kunio Yamada

Mr. Kunio Yamada has been serving as Chairman of the Board, President and Representative Director in ROHTO Pharmaceutical Co., Ltd., since August 9, 2018. He joined the Company in 1980. His previous titles include Senior Managing Director, Chief Director of Health Care Business Promotion and Vice President in the Company. He obtained his Bachelor's degree from the University of Tokyo and MBA from Keio University.

Shinichi Kunisaki

Mr. Shinichi Kunisaki has been serving as Director of Business Strategy Promotion Unit and Director in ROHTO Pharmaceutical Co., Ltd., as well as President and Representative Director of a subsidiary, since June 2018. He joined the Company in January 2007. He used to work for Suntory Co., Ltd.

Lekh Raj Juneja

Mr. Lekh Raj Juneja has been serving as Vice President, Chief Health Officer and Director in ROHTO Pharmaceutical Co., Ltd. since June 24, 2014. He joined the Company in April 2014. he used to work for Taiyo Kagaku Co., Ltd.

Masaya Saito

Mr. Masaya Saito has been serving as Vice President and Director in ROHTO Pharmaceutical Co., Ltd., as well as President and Director of a subsidiary, since June 2018. He joined the Company in April 1986. He previously served as Deputy Chief Director of Business Information in the Company.

Yoichi Kambara

Mr. Yoichi Kambara has been serving as Managing Director in ROHTO Pharmaceutical Co., Ltd. since June 2015. He joined the Company in October 2004. He used to work for two other companies.

Masako Rikiishi

Ms. Masako Rikiishi has been serving as Director of Product Marketing and Director in ROHTO Pharmaceutical Co., Ltd. since June 2018. She joined the Company in April 1982.

Hidetoshi Segi

Mr. Hidetoshi Segi has been serving as Director of Business Planning and Director in ROHTO Pharmaceutical Co., Ltd. since June 2018. He joined the Company in June 1997.

Hideto Uemura

Mr. Hideto Uemura has been serving as Director of Business Strategy Promotion Unit, Manager of Ueno Technology Center and Director in ROHTO Pharmaceutical Co., Ltd. since June 2018. He joined the Company in April 1982.

Tetsumasa Yamada

Mr. Tetsumasa Yamada has been serving as Director of Regenerative Medicine Research Planning and Director in ROHTO Pharmaceutical Co., Ltd. since June 2018. He joined the Company in August 2000.

Yasuhiro Yamada

Mr. Yasuhiro Yamada has been serving as Director in ROHTO Pharmaceutical Co., Ltd. since November 1973. He is also serving as Chairman of the Board and Representative Director in a associated company, Ands Corporation. He joined the Company in 1962. His previous titles include Managing Director and Senior Managing Director in the Company.

Mari Matsunaga

Ms. Mari Matsunaga has been serving as Independent Director in ROHTO Pharmaceutical Co., Ltd. since June 2014. She is also serving as Independent Director in MS & AD Insurance Group Holdings , Inc., BRAINS NETWORK CO., LTD., and SEIKO EPSON CORPORATION, and working for a Japan-based firm.

Shingo Torii

Mr. Shingo Torii has been serving as Independent Director in ROHTO Pharmaceutical Co., Ltd. since June 2015. He is also serving as Vice Chairman of the Board and Representative Director in Suntory Holdings Limited, as well as Director in Beam Suntory Inc.

Motohide Arai